Next Article in Journal
Development and Evaluation of AT11-Guided Liposomes for Human Papillomavirus Cancer
Previous Article in Journal
Ionic Derivatives of Insulin-Mimetic Vanadium(V) Complexes with Schiff Base Ligands
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

Impact of pH on the Antibacterial Activity of Norfloxacin in Its Combined Use with Oxalic Acid against Escherichia coli ATCC 25922 †

by
Rosalía Ayala Gómez
1,*,
María Cecilia Becerra
2 and
Graciela Pinto Vitorino
1
1
Departamento de Farmacia y Centro Regional de Investigación y Desarrollo Científico Tecnológico, Facultad de Ciencias Naturales y Ciencias de la Salud, Universidad Nacional de la Patagonia San Juan Bosco, Km. 4, Comodoro Rivadavia 9000, Argentina
2
Departamento de Ciencias Farmacéuticas, Unidad de Investigación y Desarrollo en Tecnología Farmacéutica-Consejo Nacional de Investigaciones Científicas y Técnicas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba 5000, Argentina
*
Author to whom correspondence should be addressed.
Presented at the 8th International Electronic Conference on Medicinal Chemistry, 1–30 November 2022; Available online: https://ecmc2022.sciforum.net/.
Med. Sci. Forum 2022, 14(1), 99; https://doi.org/10.3390/ECMC2022-13226
Published: 1 November 2022
(This article belongs to the Proceedings of The 8th International Electronic Conference on Medicinal Chemistry)

Abstract

:
The bacterial susceptibility and the translocation of fluoroquinolones (FQs) are influenced by pH, since it determines the proportion of microspecies of the drug. Norfloxacin (NOR) and oxalic acid (AO) are antibacterial compounds. In this work, we evaluated the antibacterial activity of the NOR–AO combination on the Escherichia coli American Type Culture Collection 25922 strain using the checkerboard method. In addition, we analyzed the effect of pH on the NOR-AO combination. We determined the extent of NOR ionization equilibrium and calculated the apparent logP to establish the lipophilicity of NOR at the different pHs assayed. The minimum inhibitory concentration (MIC) obtained for AO and NOR was 1250 µg/mL and 0.25 µg/mL, respectively. The interaction of NOR–AO was indifferent to the concentrations tested (Fractional Inhibitory Concentration 1.12). However, an atypical behavior was observed in E. coli growth. We observed that at pH values below 5.8 and log D below −0.3, the cationic species of NOR predominates, decreasing its activity. As pH increased, the predominant species is zwitterionic with increased lipophilicity and restoration of NOR activity. Therefore, the acid conditions given by the presence of AO decreased the concentration of the neutral species of NOR and therefore the amount of drug capable of diffusing directly through the membrane. There is controversy in the literature regarding the mechanism of FQ translocation through the bacterial membrane; however, our results show that the pH of the medium is a determining factor that directly impacts the antibacterial activity. To deepen this study, we will continue testing new concentrations and combinations with other organic acids.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/ECMC2022-13226/s1.

Author Contributions

Conceptualization, R.A.G.; M.C.B.; G.P.V.; methodology, R.A.G.; validation, R.A.G.; M.C.B.; G.P.V.; formal analysis, R.A.G.; G.P.V.; investigation, R.A.G.; resources, G.P.V.; writing—original draft preparation, R.A.G.; writing—review and editing, R.A.G.; G.P.V.; visualization, M.C.B.; G.P.V.; supervision, M.C.B.; G.P.V.; project administration, M.C.B.; G.P.V.; funding acquisition, G.P.V. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Secretaría de Ciencia y Técnica, Universidad Nacional de la Patagonia San Juan Bosco, Res. R/10 N° 218/22, PI N° 1712 and by Consejo Nacional de Investigaciones Científicas y Técnicas.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data is available in the Supplementary Material.

Conflicts of Interest

The authors declare no conflict of interest.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ayala Gómez, R.; Becerra, M.C.; Pinto Vitorino, G. Impact of pH on the Antibacterial Activity of Norfloxacin in Its Combined Use with Oxalic Acid against Escherichia coli ATCC 25922. Med. Sci. Forum 2022, 14, 99. https://doi.org/10.3390/ECMC2022-13226

AMA Style

Ayala Gómez R, Becerra MC, Pinto Vitorino G. Impact of pH on the Antibacterial Activity of Norfloxacin in Its Combined Use with Oxalic Acid against Escherichia coli ATCC 25922. Medical Sciences Forum. 2022; 14(1):99. https://doi.org/10.3390/ECMC2022-13226

Chicago/Turabian Style

Ayala Gómez, Rosalía, María Cecilia Becerra, and Graciela Pinto Vitorino. 2022. "Impact of pH on the Antibacterial Activity of Norfloxacin in Its Combined Use with Oxalic Acid against Escherichia coli ATCC 25922" Medical Sciences Forum 14, no. 1: 99. https://doi.org/10.3390/ECMC2022-13226

APA Style

Ayala Gómez, R., Becerra, M. C., & Pinto Vitorino, G. (2022). Impact of pH on the Antibacterial Activity of Norfloxacin in Its Combined Use with Oxalic Acid against Escherichia coli ATCC 25922. Medical Sciences Forum, 14(1), 99. https://doi.org/10.3390/ECMC2022-13226

Article Metrics

Back to TopTop